A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
2022 · Cell Research · 76 citations
https://doi.org/10.1038/s41422-022-00746-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
1.0K
Citations
16
h-index
20
i10-index
Ying Lu is an academic researcher from Northeast Electric Power University. The author has contributed to research in topics: Advanced biosensing and bioanalysis techniques & SARS-CoV-2 and COVID-19 Research & Advanced Photocatalysis Techniques. The author has an h-index of 16, co-authored 64 publications.
ORCID: 0000-0002-8967-7119https://doi.org/10.1038/s41422-022-00746-3
https://doi.org/10.3390/chemistry5030119
https://doi.org/10.6084/m9.figshare.5388034
Click to start Chat